Jianfeng Chu

1.2k total citations · 1 hit paper
70 papers, 861 citations indexed

About

Jianfeng Chu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Computer Networks and Communications. According to data from OpenAlex, Jianfeng Chu has authored 70 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 14 papers in Computer Networks and Communications. Recurrent topics in Jianfeng Chu's work include Advanced Authentication Protocols Security (11 papers), Cryptography and Data Security (11 papers) and Security in Wireless Sensor Networks (9 papers). Jianfeng Chu is often cited by papers focused on Advanced Authentication Protocols Security (11 papers), Cryptography and Data Security (11 papers) and Security in Wireless Sensor Networks (9 papers). Jianfeng Chu collaborates with scholars based in China and United States. Jianfeng Chu's co-authors include Jun Peng, Aling Shen, Youqin Chen, Jun Peng, Liya Liu, Qiaoyan Cai, Liang Hu, Thomas J. Sferra, Ying Cheng and Lihui Wei and has published in prestigious journals such as Journal of Ethnopharmacology, Advanced Science and Journal of General Internal Medicine.

In The Last Decade

Jianfeng Chu

68 papers receiving 840 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucose‐Responsive and Analgesic Gel for Diabetic Subcutaneous Abscess Treatment by Simultaneously Boosting Photodynamic Therapy and Relieving Hypoxia

2025 25 citations Jianfeng Chu, Dongliang Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianfeng Chu China	19	319	135	92	85	78	70	861
Xuejiao Liu China	28	755 2.4×	151 1.1×	231 2.5×	125 1.5×	37 0.5×	113	2.0k
Rui Wu China	18	312 1.0×	177 1.3×	61 0.7×	46 0.5×	50 0.6×	75	1.0k
Xing Wei China	19	493 1.5×	116 0.9×	174 1.9×	121 1.4×	47 0.6×	67	979
Mercedes Rigla Spain	25	190 0.6×	209 1.5×	28 0.3×	95 1.1×	34 0.4×	82	2.0k
Spyros Deftereos Greece	17	465 1.5×	206 1.5×	44 0.5×	99 1.2×	22 0.3×	51	2.0k
Wei Zuo China	22	405 1.3×	31 0.2×	75 0.8×	60 0.7×	42 0.5×	73	1.2k
Paulo Matafome Portugal	30	684 2.1×	247 1.8×	144 1.6×	88 1.0×	34 0.4×	103	2.5k
Liqian Chen China	15	599 1.9×	159 1.2×	221 2.4×	49 0.6×	13 0.2×	69	1.1k
Liu Li China	18	239 0.7×	37 0.3×	47 0.5×	120 1.4×	63 0.8×	174	1.3k
Chao Ren China	22	604 1.9×	49 0.4×	136 1.5×	75 0.9×	22 0.3×	60	1.8k

Countries citing papers authored by Jianfeng Chu

Since Specialization

Citations

This map shows the geographic impact of Jianfeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Chu more than expected).

Fields of papers citing papers by Jianfeng Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Chu. The network helps show where Jianfeng Chu may publish in the future.

Co-authorship network of co-authors of Jianfeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfeng Chu. A scholar is included among the top collaborators of Jianfeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfeng Chu. Jianfeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Jie, Yidan Zhu, Kaifu Ke, et al.. (2025). Benefits of first-pass reperfusion: secondary analysis based on three randomized multicenter trials in China. International Journal of Surgery. 111(12). 9102–9109.

Yang, Meiling, Shanyuan Zhang, Chenchen He, et al.. (2025). The Association Between Sleep Duration and the Risk of Hypertension: A Systematic Review and Meta-analysis of Cohort Studies. Journal of General Internal Medicine. 40(16). 3848–3858. 1 indexed citations

Chu, Jianfeng, et al.. (2025). Laparoscopic resection of a duplicated gall bladder: A case report and literature review. Journal of Minimal Access Surgery.

Qu, Hua, Kuo Yang, Wanqing Li, et al.. (2024). Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial. Pharmacological Research. 200. 107052–107052. 1 indexed citations

Cai, Qiaoyan, Chunyu Zhao, Yaoyao Xu, et al.. (2024). Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia. Journal of Ethnopharmacology. 324. 117712–117712. 20 indexed citations

Chen, Daxin, Shan Lin, Huajian Gao, et al.. (2022). Qingda granule alleviate angiotensin ⅱ-induced hypertensive renal injury by suppressing oxidative stress and inﬂammation through NOX1 and NF-κB pathways. Biomedicine & Pharmacotherapy. 153. 113407–113407. 10 indexed citations

Wang, Tianyi, et al.. (2022). Lipid-Lowering Efficacy of Kuding Tea in Patients With Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Nutrition. 9. 802687–802687. 3 indexed citations

Zhang, Xiuli, Ying Wen, Lihui Wei, et al.. (2022). Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway. Frontiers in Pharmacology. 12. 770863–770863. 17 indexed citations

Wang, Cong, Guichen Li, Lufang Zheng, et al.. (2021). Effects of music intervention on sleep quality of older adults: A systematic review and meta-analysis. Complementary Therapies in Medicine. 59. 102719–102719. 26 indexed citations

10.

Cheng, Ying, Jianfeng Chu, Meizhu Wu, et al.. (2021). Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway. Biomedicine & Pharmacotherapy. 143. 112124–112124. 26 indexed citations

11.

Cheng, Ying, Jianfeng Chu, Zhiqing Shen, et al.. (2021). Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo. Biomedicine & Pharmacotherapy. 137. 111318–111318. 25 indexed citations

12.

Huang, Bin, Yuanpeng J. Huang, Han Han, et al.. (2021). An NIR-II Responsive Nanoplatform for Cancer Photothermal and Oxidative Stress Therapy. Frontiers in Bioengineering and Biotechnology. 9. 751757–751757. 14 indexed citations

13.

Shen, Zhiqing, Youqin Chen, Li Li, et al.. (2020). Transcription Factor EBF1 Over-Expression Suppresses Tumor Growth in vivo and in vitro via Modulation of the PNO1/p53 Pathway in Colorectal Cancer. Frontiers in Oncology. 10. 1035–1035. 15 indexed citations

14.

Shen, Zhiqing, Xiangyan Wu, Jianfeng Chu, et al.. (2020). Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-β1/Smad2/3 pathways. Biomedicine & Pharmacotherapy. 130. 110618–110618. 18 indexed citations

15.

Yang, Meiling, Aling Shen, Yan Lu, et al.. (2020). Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats. Chinese Journal of Integrative Medicine. 27(6). 424–431. 5 indexed citations

16.

Yu, Na, Aling Shen, Jianfeng Chu, et al.. (2020). Qingda granule inhibits angiotensin Ⅱ induced VSMCs proliferation through MAPK and PI3K/AKT pathways. Journal of Ethnopharmacology. 258. 112767–112767. 21 indexed citations

17.

Chen, Hongwei, Aling Shen, Liya Liu, Jun Peng, & Jianfeng Chu. (2019). Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice. Chinese Journal of Integrative Medicine. 26(5). 370–374. 9 indexed citations

18.

Wan, Yun, Aling Shen, Fei Qi, et al.. (2017). Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p. Experimental and Therapeutic Medicine. 14(4). 3901–3907. 33 indexed citations

19.

Chu, Jianfeng, Aling Shen, Liya Liu, et al.. (2017). Pien Tze Huang alleviates 5-fluorouracil-induced intestinal mucositis in CT-26 tumor-bearing mice. Experimental and Therapeutic Medicine. 14(3). 2291–2297. 18 indexed citations

20.

Chu, Jianfeng. (2011). Systematic Review of Randomized Controlled Trials of Aloe Application to Preventing Transfusion Phlebitis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact